A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE4
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
- Status
- COMPLETED
- Phase
- N/A
Gastrointestinal Motility Among Diabetes Patients
- Status
- TERMINATED
- Phase
- NA
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
- Status
- COMPLETED
- Phase
- N/A
Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
- Status
- COMPLETED
- Phase
- PHASE1
Antiproteinuric Effects of Liraglutide Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Patient Experiences With Injection Needles
- Status
- COMPLETED
- Phase
- NA
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Pedometer Intervention and Health Effects for Sedentary Colorectal Cancer Patients During Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- NA
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study.
- Status
- COMPLETED
- Phase
- N/A